Adapt Enterprise-ready Domain-trained AI
Adapt Enterprise-ready Domain-trained AI
Generative AI for Pharma
Generative AI goes beyond creating text, images, videos, and audio. Discover how Pharma teams use generative AI to innovate and enhance their capabilities across departments with Ariya.
Ariya Knowledge Wizard
Understand Pharmaceutical Data with AI
Ariya empowers pharmaceutical professionals to better understand and utilize their scientific, medical, and commercial information by providing easy-to-generate contextual summaries and insights through our domain-trained AI in a conversational manner.
Ariya Content Wizard
Generate Pharma Compliant Content with AI
Shorten time-to-market by rapidly generating, reviewing, and distributing compliant scientific and commercial content through our brand-trained, unified AI platform.
Ariya Customer Wizard
Enhance Customer Engagement
Customer Wizard leverages generative AI to empower sales reps and MSLs to enhance customer understanding and engagement by delivering relevant information in a timely manner, thereby improving engagement and satisfaction.
We Solve Practical Problems
What Sets Us Apart in the Industry
Domain-Specific
Ariya leverages a generative AI architecture tailored to the pharmaceutical industry and enterprise requirements to address industry-specific challenges and enhance operational efficiency.
Human-in-the-loop
Ariya's generative AI ensures critical decisions are made with both data-driven insights and human judgment through human-in-the-loop integration.
Enterprise-grade
In Ariya, we ensure data security and access controls meet stringent privacy and deployment standards for pharmaceutical workflows, achieving enterprise-grade protection.
Hallucination-free
Ariya provide responses with integrated domain-specific conditioning to ensure accuracy and eliminate hallucinations.
Responsible AI
We design our solutions to meet the strict regulatory requirements of the pharmaceutical industry, ensuring responsible AI practices
Instant Access
Ariya provides instant access to relevant, critical, and high-value insights from both internal pharmaceutical systems and external sources.